Burning Rock Biotech Ltd

BNR

Company Profile

  • Business description

    Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

  • Contact

    No. 5, Xingdao Ring Road North
    International Bio Island
    Guangzhou510005
    CHN

    T: +86 2034037871

    https://www.brbiotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    674

Stocks News & Analysis

stocks

Netflix and Warner Bros. Discovery: Surprisingly high merger price alters shareholder value for both

Our view on the blockbuster merger.
stocks

The trillion-dollar club: Are these mega-sized stocks still buys?

The biggest stocks got bigger this year, breaking multi-trillion-dollar milestones.
stocks

New pricing model for embattled ASX tech leader

Investor day shows off potentially disruptive pricing model.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,926.1019.300.22%
CAC 408,114.747.29-0.09%
DAX 4024,028.14146.110.61%
Dow JONES (US)47,954.99104.050.22%
FTSE 1009,667.0143.86-0.45%
HKSE26,085.08149.180.58%
NASDAQ23,578.1372.990.31%
Nikkei 22550,491.87536.55-1.05%
NZX 50 Index13,483.9931.63-0.23%
S&P 5006,870.4013.280.19%
S&P/ASX 2008,634.6020.500.24%
SSE Composite Index3,902.8127.010.70%

Market Movers